242 related articles for article (PubMed ID: 10398089)
1. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
Tanabe H; Yokota K; Kohgo Y
J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
[TBL] [Abstract][Full Text] [Related]
2. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
3. Expression of proteoglycan core proteins in human bone marrow stroma.
Schofield KP; Gallagher JT; David G
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
[TBL] [Abstract][Full Text] [Related]
4. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
[TBL] [Abstract][Full Text] [Related]
5. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
6. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells.
Sun H; Berquin IM; Edwards IJ
Cancer Res; 2005 May; 65(10):4442-7. PubMed ID: 15899837
[TBL] [Abstract][Full Text] [Related]
8. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-1 in B lymphoid malignancies.
Sanderson RD; Børset M
Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
[TBL] [Abstract][Full Text] [Related]
10. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.
Gulyás M; Hjerpe A
J Pathol; 2003 Apr; 199(4):479-87. PubMed ID: 12635139
[TBL] [Abstract][Full Text] [Related]
11. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
Yamagata E; Kamada A
J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
[TBL] [Abstract][Full Text] [Related]
12. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K; Nurminen M; Hjerpe A
Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
[TBL] [Abstract][Full Text] [Related]
13. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal expression patterns of N-syndecan, a transmembrane heparan sulfate proteoglycan, in developing retina.
Inatani M; Honjo M; Oohira A; Kido N; Otori Y; Tano Y; Honda Y; Tanihara H
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1616-21. PubMed ID: 11980882
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression of the syndecans: possible function and regulation.
Bernfield M; Hinkes MT; Gallo RL
Dev Suppl; 1993; ():205-12. PubMed ID: 8049475
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 expression during postnatal tooth and oral mucosa development in rats aged from two days to six weeks.
De Angelis DD; Sampson WJ; Wiebkin OW; Wilson DF
Aust Orthod J; 2002 Mar; 18(1):1-6. PubMed ID: 12502123
[TBL] [Abstract][Full Text] [Related]
17. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis.
Salminen-Mankonen H; Säämänen AM; Jalkanen M; Vuorio E; Pirilä L
Scand J Rheumatol; 2005; 34(6):469-74. PubMed ID: 16393771
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.
Sneed TB; Stanley DJ; Young LA; Sanderson RD
Cell Immunol; 1994 Feb; 153(2):456-67. PubMed ID: 8118875
[TBL] [Abstract][Full Text] [Related]
20. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
